Karin Haustermans
机构: Professor in Radiation Oncology
每年引用次数
引用次数
引用: 35,887
H-指数: 85
I10-指数 : 290
出版物: 870
Digital exchange of images and contours : radiological/oncological cooperation in radiotherapy planning for head and neck tumors
Guy Marchal , Karin Haustermans , Robert Hermans , Walter Van den Bogaert
EuroPACS Proceedings '97
1997
Adjuvant RT is associated with better cancer control compared to early salvage RT in patients with prostate cancer: results of a matched-controlled multi-institutional analysis
U Capitanio , P Scalliet , T Budiharto , S Junius
Radiotherapy and Oncology 96
2010
Behandeling op maat voor het rectumcarcinoom
Karin Haustermans
Onco 6 ( 7) 18 -21
2012
Are colorectal adenocarcinomas hypoxic
A. Debucquoy , C. Perneel , Nadine Ectors , W. McBride
Radiotherapy and Oncology 73
2004
Acute en laattijdige nevenwerkingen bij de bestraling van het rectumcarcinoom
Ines Joye , Karin Haustermans
Oncologisch Tijdschrift 31 ( 3) 26 -31
2014
Estimating acute and chronic hypoxia in head and neck cancer patiens: a pilotstudy
J. Raleigh , I. Hofland , Pierre Delaere , A. Balm
Abstract book of Aarhus 17 64 -64
2001
Adjuvant chemoradiation after curative resection for pancreatic cancer is feasible: Results of a randomised EORTC/FFCD/GERCOR study
F. Mornex , Eric Van Cutsem , P. Hammel , D. Azria
Annals of Oncology 19 008 -008
2008
The adjuvant treatment of gastric cancer
Karin Haustermans , Eric Van Cutsem
GI Oncology and Innovative Aspects in Gastrointestinal Cancers 83 -86
2005
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Response to the local treatment after chemoradiation and surgery as secondary endpoint
Eric Van Cutsem , T Price , H. J Schmoll , J. F Daisne
European Journal of Cancer 49
6
2013
Phase 1 study to identify tumor hypoxia in head and neck cancer patients using Tc-99m BRU 59-21
F. Hoebers , A. Nunn , R. Valdes Olmos , A. Balm
Radiotherapy and Oncology 64
2000
Can cytokeratin gating be used to enrich tumor cells for cell kinetic analysis
I. Hofland , Karin Haustermans , A.C. Begg
British Journal of Radiology 69 822 -822
1996
FOXP1 expression in colorectal cancer
Gert De Hertogh , André D'Hoore , Xavier Sagaert , E. Cutsem
Histopathology 57 95 -95
2010
Case 10.2: Cidoton University Hospital (Belgium)
J. Van Thillo , B. Holthof , Karin Haustermans
Springer Verlag
1995
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
Eric Van Cutsem , J. R Zalcberg , S Marreaud , F. W. B Fauth
Onkologie 39 197 -197
2016
Reduction of kidney toxicity from 90Y-DOTATOC PRRT through individualized 111In-pentetreotide dosimetry
Eric Van Cutsem , Sofie Van Binnebeek , Christophe Deroose , Chris Verslype
Society of Nuclear Medicine Annual Meeting Abstracts 54 1377
2013
The addition of the PARP inhibitor olaparib to ionizing radiation delays tumor growth in an in vivo rectal cancer model
Annelies Debucquoy , Philippe Bulens , Karin Haustermans , Anthony Chalmers
Oncoforum, Date: 2016/05/27 - 2016/05/27, Location: Leuven, Belgium
2016
The use of diffusion weighted mri for the prediction of pathological response in rectal cancer treated with preoperative chemoradiotherapy
Eric Van Cutsem , Freddy Penninckx , M Lambrecht , S Roels
Annals of Oncology 21
2010
The potential of proton therapy in oesophageal cancer treatment
Maarten Lambrecht , Melissa Thomas , Karin Haustermans
Belgian Journal of Medical Oncology 13 ( 1) 11 -15
2019
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort.
Riccardo Valdagni , Renée Bultijnck , Renée Bultijnck , Miguel E. Aguado-Barrera
Frontiers in Oncology 10 575909 -575909
1
2020
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial
Sofie Isebaert , Linda G W Kerkmeijer , Linda G W Kerkmeijer , Martina Kunze-Busch
Journal of Clinical Oncology 39 ( 7) 787 -796
189
2021